VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,126,643 | -1.7% | 14,006,939 | +16.6% | 0.14% | -1.4% |
| Q2 2023 | $424,452,484 | +160.9% | 12,010,540 | +119.6% | 0.15% | +108.6% |
| Q4 2022 | $162,694,510 | -8.4% | 5,468,723 | -25.0% | 0.07% | -7.9% |
| Q3 2022 | $177,535,000 | -51.2% | 7,290,925 | -19.1% | 0.08% | -55.0% |
| Q2 2022 | $363,476,000 | +64.5% | 9,012,534 | +57.7% | 0.17% | +57.9% |
| Q1 2022 | $220,995,000 | +17.9% | 5,714,878 | +4.9% | 0.11% | +8.1% |
| Q4 2021 | $187,505,000 | -64.1% | 5,447,586 | -65.9% | 0.10% | -58.6% |
| Q3 2021 | $522,967,000 | +286.2% | 15,968,434 | +313.0% | 0.24% | +256.7% |
| Q2 2021 | $135,408,000 | +52.7% | 3,866,531 | +51.4% | 0.07% | +15.5% |
| Q1 2021 | $88,674,000 | -3.9% | 2,553,231 | -1.0% | 0.06% | -4.9% |
| Q4 2020 | $92,308,000 | -47.0% | 2,579,888 | -43.6% | 0.06% | -57.9% |
| Q3 2020 | $174,247,000 | -42.3% | 4,572,217 | -41.3% | 0.14% | -47.3% |
| Q2 2020 | $301,956,000 | +468.7% | 7,784,402 | +267.1% | 0.28% | +350.8% |
| Q1 2020 | $53,096,000 | -51.3% | 2,120,431 | -43.1% | 0.06% | -24.7% |
| Q4 2019 | $109,049,000 | -8.4% | 3,724,364 | -16.5% | 0.08% | -20.6% |
| Q3 2019 | $119,102,000 | +173.5% | 4,459,042 | +161.7% | 0.10% | +175.7% |
| Q2 2019 | $43,549,000 | -18.9% | 1,703,807 | -28.9% | 0.04% | -19.6% |
| Q1 2019 | $53,699,000 | +30.2% | 2,395,144 | +22.5% | 0.05% | +17.9% |
| Q4 2018 | $41,239,000 | -17.8% | 1,955,425 | -27.8% | 0.04% | 0.0% |
| Q3 2018 | $50,160,000 | +26.5% | 2,708,396 | +52.4% | 0.04% | +21.9% |
| Q2 2018 | $39,642,000 | +178.5% | 1,776,873 | +174.4% | 0.03% | +166.7% |
| Q1 2018 | $14,232,000 | -61.1% | 647,485 | -58.8% | 0.01% | -61.3% |
| Q4 2017 | $36,543,000 | -21.8% | 1,572,442 | -22.7% | 0.03% | -27.9% |
| Q3 2017 | $46,717,000 | -85.3% | 2,034,714 | -85.8% | 0.04% | -85.8% |
| Q2 2017 | $316,734,000 | -28.9% | 14,344,847 | -26.6% | 0.30% | -28.2% |
| Q1 2017 | $445,691,000 | +189.9% | 19,539,237 | +164.8% | 0.42% | +160.5% |
| Q4 2016 | $153,724,000 | +523.8% | 7,379,940 | +691.5% | 0.16% | +500.0% |
| Q3 2016 | $24,643,000 | -93.9% | 932,368 | -93.6% | 0.03% | -94.1% |
| Q2 2016 | $403,488,000 | – | 14,561,061 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |